Inheritances and legacies

Her legacy for clinical cancer research – a ray of hope for those affected

The focus of clinical cancer research is on Swiss patients: new therapies are being researched, existing treatments are being further developed and measures that have a positive impact on quality of life are being tested. New findings are immediately applied for the benefit of people with cancer. The Swiss Cancer Institute is a research institution of national importance and connects all university hospitals as well as all leading cantonal, regional and private hospitals in Switzerland. Studies are conducted for all types of cancer – including those that are rare and therefore poorly researched. Each study conducted by the Swiss Cancer Institute is reviewed in advance by the Patient Advisory Board. 

By leaving a legacy to the Swiss Cancer Institute, you will enable practical, independent, non-profit research and contribute to improving cancer treatments for the Swiss population. 100% of your legacy will go towards clinical research: the Swiss Cancer Institute is exempt from inheritance and gift tax.

We are happy to answer some basic questions about wills on this page. Please contact us confidentially and without obligation if you are considering including the Swiss Cancer Institute in your will alongside your relatives and friends.

  • With your legacy, you will enable independent clinical cancer research for a longer life and better quality of life. For all types of cancer and for all those affected throughout Switzerland.

Practical information for you

Forms of preferential treatment

Legacy: With a bequest or legacy, you can leave a specific amount of money or assets (e.g. real estate, works of art, jewellery) to the Swiss Cancer Institute.

Appointment as heir: It is also possible to appoint the Swiss Cancer Institute as a co-heir. In this case, the Swiss Cancer Institute becomes a member of the community of heirs. If there are no relatives who are entitled to a compulsory portion, the Swiss Cancer Institute can also be named as sole heir in your will.

Insurance benefits: For any death or pension insurance policy with a surrender value, as well as for pillar 3b life insurance (and, to a limited extent, for tied pension insurance 3a), you can name your relatives and the Swiss Cancer Institute as beneficiaries, for example, each receiving half. Notify the insurance company of your beneficiaries by registered letter or specify them accordingly in your will. 

Foundation or fund: Large estates may be a reason to set up your own fund or foundation. When these are established, it is determined which charitable purposes the income from the estate will fulfil and which beneficiaries should be mentioned in the supplementary statutes.